In episode 186 of The Hoban Minute, Bob and Xavier tackle a much-requested topic: hemp THCA flower. Like many things hemp, THCA flower is a controversial topic in the cannabis industry currently. Is it legal? Is it just marijuana by another name? Tune in to hear the host’s thoughts on the topic.

While this podcast never constitutes legal advice, the legality of THCA flower is a particularly nuanced topic that requires Bob and Xavier to describe and analyze both botanic and legal topics so we want to remind our listeners that this podcast is not legal advice. Reach out to a licensed and knowledgeable attorney for legal advice specific to your circumstances. Bob’s 5 part series on hemp and marijuana can be read on his Forbes page here.

In the second episode of 2024, Bob and Xavier jump into the podcast booth with cannabis industry attorney, Thomas Howard to discuss their predictions for the industry in 2024. The three industry insiders discuss the recent news that THM listeners may have missed over the holiday break before pulling out their crystal balls and looking to the future. The conversation covers several topics ranging from federal to state markets, the continued emergence of the hemp-derived cannabinoid industry, the impact a Schedule III move might have on the existing cannabis industry, the “dog fight” that will be the 2024 election – and how cannabis will be an important topic for all parties, and how capital relief needs to found quickly for the current industry to survive. Tune in to prepare yourself and your business for 2024 in the cannabis industry!

Bob’s 5 part series on hemp and marijuana can be read on his Forbes page here.

In their annual holiday recap episode, Bob and Xavier reflect on top headline news from the cannabis industry in 2023. They start with the HHS recommendation to move marijuana from Schedule 1 to Schedule 3, including a discussion of the impact rescheduling would have on the industry.

Hint: DESCHEDULE OR BUST is not a realistic approach to getting meaningful change at the federal level. Bob and Xavier then pivot to discuss state-level headlines regarding new medical and adult-use marijuana markets and intoxicating hemp derivative regulations.

They provide an analysis as to the future of the market and how the marijuana and hemp industries are on a collision course with each other. They also cover one of the largest state-specific stories of 2023: the collapse of HERBL in California and how that is indicative of greater issues with collections and payments in the industry generally. Finally, Bob and Xavier discuss testing fraud issues and how they will impact regulating the cannabis industry moving forward. See you in 2024!

Bob’s 5 part series on hemp and marijuana can be read on his Forbes page here.

Back from a break in the podcast studio, Bob and Xavier jump right back into the swing of reporting on important news stories in the cannabis industry. First, they discuss their experience in Las Vegas for “weed week,” also known as MJBizCon, including covering post-conference feedback and how conference organizers may be able to bolster the value of the conference in the future. After wrapping up their recap, Bob and Xavier move to cover recent headline news in the industry: Ohio’s legalization vote, Colombia deciding to shelve legalization efforts for the moment, and a discussion of the Farm Bill being extended another year, including a conversation about recent “controversies” between hemp and marijuana operators. Finally, Bob and Xavier generally discuss cannabis beverages and their impact on the current market and how they will continue to be a leading product form in the next decade. The main message? D9 THC is D9 THC – regardless of whether it came from a plant legally defined as “hemp” or “marijuana.”

Bob’s 5 part series on hemp and marijuana can be read on his Forbes page here.

In this week’s episode of The Hoban Minute, Bob and Xavier are joined by Blunt Strategies’ principals Laura Monn Ginsburg and Leili Fatehi. Leili and Laura are fresh off a successful adult-use legalization campaign in Minnesota that which Blunt Strategies played a central role. Bob and Xavier ask Leili and Laura about the current sentiment in MN’s cannabis industry, their push to integrate hemp-derived cannabinoid products included in the adult-use framework, how cannabis brands can tap into new market segments, and how other jurisdictions can learn from the evolution of policy in the United States’ cannabis industry. Tune in to learn more about opportunities in MN and how regulators around the world should approach cannabis policy.

Sharing Blunt Strategies social links below for ease of reference:

Instagram

Facebook

Twitter

LinkedIn